Presented:

NeoGenomics Reports 18% Revenue Growth to $126 Million in the Fourth Quarter

Read Now

Presented:

NeoGenomics Announces CEO Succession

Read Now

Presented:

NeoGenomics to Participate in the BTIG Virtual Medtech, Digital Health, Life Science & Diagnostic Tools Conference

Read Now

Presented:

NeoGenomics Schedules its Fourth Quarter and Full Year 2020 Earnings Release for February 24, 2021

Read Now

Presented:

Parexel and NeoGenomics Announce Strategic Collaboration in Precision Medicine to Improve Study Designs and Accelerate Patient Matching in Oncology Clinical Trials

Read Now

Presented:

NeoGenomics and Tempus Join the Access to Comprehensive Genomic Profiling Coalition

Read Now

Presented:

NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes

Read Now

Presented:

NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes

Read Now

Presented:

NeoGenomics To Virtually Participate In The 39th Annual J.P. Morgan Healthcare Conference

Read Now

Presented:

NeoGenomics to Offer Mobile Phlebotomy Services for Liquid Biopsy Tests

Read Now